Steven Cohen Rezolute, Inc. Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Rezolute, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,157,410 shares of RZLT stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,157,410
Previous 211,509
447.22%
Holding current value
$11.5 Million
Previous $943,000
1040.19%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
123Shares Held
68.9MCall Options Held
1.01MPut Options Held
57.2K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$139 Million0.25% of portfolio
-
Siren, L.L.C. New York, NY4.87MShares$48.3 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$43.7 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.02MShares$30 Million0.13% of portfolio
-
Mangrove Partners New York, NY2.88MShares$28.6 Million3.44% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $385M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...